Rizzo M - Search Results

1

The Dual Pandemics of COVID-19 and Obesity: Bidirectional Impact.

Kapoor N, Kalra S, Al Mahmeed W, Al-Rasadi K, Al-Alawi K, Banach M, Banerjee Y, Ceriello A, Cesur M, Cosentino F, Firenze A, Galia M, Goh SY, Janez A, Kempler P, Lessan N, Lotufo P, Papanas N, Rizvi AA, Sahebkar A, Santos RD, Stoian AP, Toth PP, Viswanathan V, Rizzo M; CArdiometabolic Panel of International experts on Syndemic COvid-19 (CAPISCO). Kapoor N, et al. Among authors: rizzo m. Diabetes Ther. 2022 Oct;13(10):1723-1736. doi: 10.1007/s13300-022-01311-2. Epub 2022 Aug 27. Diabetes Ther. 2022. PMID: 36030317 Free PMC article. Review.

2

The therapeutic modulation of atherogenic dyslipidemia and inflammatory markers in the metabolic syndrome: what is the clinical relevance?

Rizzo M, Rizvi AA, Rini GB, Berneis K. Rizzo M, et al. Acta Diabetol. 2009 Mar;46(1):1-11. doi: 10.1007/s00592-008-0057-4. Epub 2008 Oct 17. Acta Diabetol. 2009. PMID: 18925358 Review.

3

Atherogenic lipoprotein phenotype and LDL size and subclasses in drug-naïve patients with early rheumatoid arthritis.

Rizzo M, Spinas GA, Cesur M, Ozbalkan Z, Rini GB, Berneis K. Rizzo M, et al. Atherosclerosis. 2009 Dec;207(2):502-6. doi: 10.1016/j.atherosclerosis.2009.07.015. Epub 2009 Jul 8. Atherosclerosis. 2009. PMID: 19643412

4

Glucose lowering and anti-atherogenic effects of incretin-based therapies: GLP-1 analogues and DPP-4-inhibitors.

Rizzo M, Rizvi AA, Spinas GA, Rini GB, Berneis K. Rizzo M, et al. Expert Opin Investig Drugs. 2009 Oct;18(10):1495-503. doi: 10.1517/14728220903241633. Expert Opin Investig Drugs. 2009. PMID: 19758106 Free article. Review.

5

The role of elevated growth hormone on the increased atherosclerosis in patients with acromegaly.

Rizzo M, Montalto G, Rizvi AA, Christ ER. Rizzo M, et al. Angiology. 2012 Oct;63(7):492-4. doi: 10.1177/0003319712436578. Epub 2012 Feb 26. Angiology. 2012. PMID: 22371625 No abstract available.

6

The effects of statins on blood pressure: current knowledge and future perspectives.

Rizzo M, Montalto G, Banach M. Rizzo M, et al. Arch Med Sci. 2012 Feb 29;8(1):1-3. doi: 10.5114/aoms.2012.27270. Arch Med Sci. 2012. PMID: 22457664 Free PMC article. No abstract available.

7

Lipid-lowering therapies and achievement of LDL-cholesterol targets.

Rizzo M, Banach M, Montalto G, Mikhailidis DP. Rizzo M, et al. Arch Med Sci. 2012 Sep 8;8(4):598-600. doi: 10.5114/aoms.2012.30281. Arch Med Sci. 2012. PMID: 23056067 Free PMC article. No abstract available.

8

A review of the cardiovascular and anti-atherogenic effects of ghrelin.

Rizzo M, Rizvi AA, Sudar E, Soskic S, Obradovic M, Montalto G, Boutjdir M, Mikhailidis DP, Isenovic ER. Rizzo M, et al. Curr Pharm Des. 2013;19(27):4953-63. doi: 10.2174/1381612811319270018. Curr Pharm Des. 2013. PMID: 23278489 Review.

9

Combined dyslipidemia: should the focus be LDL cholesterol or atherogenic dyslipidemia?

Rizzo M, Barylski M, Rizvi AA, Montalto G, Mikhailidis DP, Banach M. Rizzo M, et al. Curr Pharm Des. 2013;19(21):3858-68. doi: 10.2174/13816128113199990324. Curr Pharm Des. 2013. PMID: 23286436 Review.

10

Effects of statins on lipid profile in chronic kidney disease patients: a meta-analysis of randomized controlled trials.

Nikolic D, Nikfar S, Salari P, Rizzo M, Ray KK, Pencina MJ, Mikhailidis DP, Toth PP, Nicholls SJ, Rysz J, Abdollahi M, Banach M; Lipid and Blood Pressure Meta-Analysis Collaboration Group. Nikolic D, et al. Among authors: rizzo m. Curr Med Res Opin. 2013 May;29(5):435-51. doi: 10.1185/03007995.2013.779237. Epub 2013 Mar 11. Curr Med Res Opin. 2013. PMID: 23427811 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,302 results

Search Page